A detailed history of Uma Financial Services, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Uma Financial Services, Inc. holds 530 shares of VRTX stock, worth $216,335. This represents 0.04% of its overall portfolio holdings.

Number of Shares
530
Previous 557 4.85%
Holding current value
$216,335
Previous $261,000 5.75%
% of portfolio
0.04%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$460.0 - $505.78 $12,420 - $13,656
-27 Reduced 4.85%
530 $246,000
Q2 2024

Jul 17, 2024

BUY
$392.81 - $485.53 $218,795 - $270,440
557 New
557 $261,000
Q1 2022

May 05, 2022

SELL
$221.42 - $260.97 $205,699 - $242,441
-929 Closed
0 $0
Q4 2021

Jan 11, 2022

BUY
$177.01 - $223.45 $164,442 - $207,585
929 New
929 $206,000
Q2 2021

Jul 23, 2021

SELL
$187.49 - $221.1 $181,302 - $213,803
-967 Closed
0 $0
Q1 2021

Apr 06, 2021

BUY
$207.02 - $241.31 $200,188 - $233,346
967 New
967 $208,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.